Similar articles

• Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.

  Akama H, Noshiro T, Kimura N, Shimizu K, Watanabe T, Shibukawa S, Nakai S, Miura W, Ito S, Miura Y. Akama H, et al. Intern Med. 1999 Feb;38(2):145-9. doi: 10.2169/internalmedicine.38.145. Intern Med. 1999. PMID: 10225670
• Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.

  Moers AM, Landsvater RM, Schaap C, Jansen-Schillhorn van Veen JM, de Valk IA, Blijham GH, Höppener JW, Vroom TM, van Amstel HK, Lips CJ. Moers AM, et al. Am J Med. 1996 Dec;101(6):635-41. doi: 10.1016/s0002-9343(96)00330-0. Am J Med. 1996. PMID: 9003111
• Composite phaeochromocytoma-ganglioneuroblastoma in a patient with multiple endocrine neoplasia type IIA.

  Matias-Guiu X, Garrastazu MT. Matias-Guiu X, et al. Histopathology. 1998 Mar;32(3):281-2. doi: 10.1046/j.1365-2559.1998.0372g.x. Histopathology. 1998. PMID: 9568520 No abstract available.
• Multiple endocrine neoplasia type 2: clinical aspects.

  Gimm O. Gimm O. Front Horm Res. 2001;28:103-30. doi: 10.1159/000061050. Front Horm Res. 2001. PMID: 11443849 Review. No abstract available.
• Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.

  Eng C, Mulligan LM. Eng C, et al. Hum Mutat. 1997;9(2):97-109. doi: 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.0.CO;2-M. Hum Mutat. 1997. PMID: 9067749 Review.